129 related articles for article (PubMed ID: 38097134)
21. The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress.
Chen W; Lian W; Yuan Y; Li M
Cell Death Dis; 2019 Aug; 10(8):600. PubMed ID: 31395855
[TBL] [Abstract][Full Text] [Related]
22. Structural Insights into the Role of Diphthamide on Elongation Factor 2 in mRNA Reading-Frame Maintenance.
Pellegrino S; Demeshkina N; Mancera-Martinez E; Melnikov S; Simonetti A; Myasnikov A; Yusupov M; Yusupova G; Hashem Y
J Mol Biol; 2018 Aug; 430(17):2677-2687. PubMed ID: 29886014
[TBL] [Abstract][Full Text] [Related]
23. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
24. Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential.
Luo ZD; Wang YF; Zhao YX; Yu LC; Li T; Fan YJ; Zeng SJ; Zhang YL; Zhang Y; Zhang X
World J Gastroenterol; 2023 Jan; 29(1):1-18. PubMed ID: 36683709
[TBL] [Abstract][Full Text] [Related]
25. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
[TBL] [Abstract][Full Text] [Related]
26. Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic.
Vucenik I; Shamsuddin AM
J Nutr; 2003 Nov; 133(11 Suppl 1):3778S-3784S. PubMed ID: 14608114
[TBL] [Abstract][Full Text] [Related]
27. MiR-744 mediates the Oxaliplatin chemoresistance in colorectal cancer through inhibiting BIN1.
Zhou Y; He A; Zhang L; Yi G
Neoplasma; 2020 Mar; 67(2):296-303. PubMed ID: 31884801
[TBL] [Abstract][Full Text] [Related]
28. A novel mechanism underlying phytate-mediated biological action-phytate hydrolysates induce intracellular calcium signaling by a Gαq protein-coupled receptor and phospholipase C-dependent mechanism in colorectal cancer cells.
Suzuki T; Nishioka T; Ishizuka S; Hara H
Mol Nutr Food Res; 2010 Jul; 54(7):947-55. PubMed ID: 20146267
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (
Combès E; Andrade AF; Tosi D; Michaud HA; Coquel F; Garambois V; Desigaud D; Jarlier M; Coquelle A; Pasero P; Bonnefoy N; Moreaux J; Martineau P; Del Rio M; Beijersbergen RL; Vezzio-Vie N; Gongora C
Cancer Res; 2019 Jun; 79(11):2933-2946. PubMed ID: 30987998
[TBL] [Abstract][Full Text] [Related]
30. Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells.
Zi X; Singh RP; Agarwal R
Carcinogenesis; 2000 Dec; 21(12):2225-35. PubMed ID: 11133812
[TBL] [Abstract][Full Text] [Related]
31. Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target.
Liu G; Song Y; Cui L; Wen Z; Lu X
Int J Clin Exp Pathol; 2015; 8(2):1402-10. PubMed ID: 25973024
[TBL] [Abstract][Full Text] [Related]
32. Induction of the expression of genes encoding TGF-beta isoforms and their receptors by inositol hexaphosphate in human colon cancer cells.
Kapral M; Wawszczyk J; Hollek A; Weglarz L
Acta Pol Pharm; 2013; 70(2):357-63. PubMed ID: 23614294
[TBL] [Abstract][Full Text] [Related]
33. The diphthamide modification on elongation factor-2 renders mammalian cells resistant to ricin.
Gupta PK; Liu S; Batavia MP; Leppla SH
Cell Microbiol; 2008 Aug; 10(8):1687-94. PubMed ID: 18460012
[TBL] [Abstract][Full Text] [Related]
34. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
[TBL] [Abstract][Full Text] [Related]
35. TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages.
Liu Z; Xie Y; Xiong Y; Liu S; Qiu C; Zhu Z; Mao H; Yu M; Wang X
Cancer Lett; 2020 Jan; 469():173-185. PubMed ID: 31629935
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268
[TBL] [Abstract][Full Text] [Related]
37. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer.
Xu Y; Hao J; Chen Q; Qin Y; Qin H; Ren S; Sun C; Zhu Y; Shao B; Zhang J; Wang H
Mol Carcinog; 2024 Feb; 63(2):224-237. PubMed ID: 37861356
[TBL] [Abstract][Full Text] [Related]
39. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
40. Application of Inositol Hexaphosphate and Inositol in Dental Medicine: An Overview.
Druzijanic A; Kovic M; Roguljic M; Cigic L; Majstorovic M; Vucenik I
Biomolecules; 2023 May; 13(6):. PubMed ID: 37371493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
